vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and Rocket Companies, Inc. (RKT). Click either name above to swap in a different company.

Rocket Companies, Inc. is the larger business by last-quarter revenue ($2.7B vs $1.6B, roughly 1.6× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 2.5%, a 20.6% gap on every dollar of revenue. On growth, Rocket Companies, Inc. posted the faster year-over-year revenue change (52.2% vs 16.7%). Over the past eight quarters, Rocket Companies, Inc.'s revenue compounded faster (39.5% CAGR vs 9.7%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Rocket Companies, Inc., is an American fintech and homeownership services company. Founded by Dan Gilbert and based in Downtown Detroit, Michigan, the company is one of the largest mortgage lenders in the United States through its flagship subsidiary Rocket Mortgage. Its subsidiaries include Redfin, Forsalebyowner.com, and Rocket Money.

EW vs RKT — Head-to-Head

Bigger by revenue
RKT
RKT
1.6× larger
RKT
$2.7B
$1.6B
EW
Growing faster (revenue YoY)
RKT
RKT
+35.5% gap
RKT
52.2%
16.7%
EW
Higher net margin
EW
EW
20.6% more per $
EW
23.1%
2.5%
RKT
Faster 2-yr revenue CAGR
RKT
RKT
Annualised
RKT
39.5%
9.7%
EW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EW
EW
RKT
RKT
Revenue
$1.6B
$2.7B
Net Profit
$380.7M
$68.0M
Gross Margin
78.0%
Operating Margin
1.8%
6.3%
Net Margin
23.1%
2.5%
Revenue YoY
16.7%
52.2%
Net Profit YoY
6.8%
100.8%
EPS (diluted)
$0.66
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
RKT
RKT
Q1 26
$1.6B
Q4 25
$1.6B
$2.7B
Q3 25
$1.6B
$1.6B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$1.0B
Q4 24
$1.4B
$1.8B
Q3 24
$1.4B
$646.9M
Q2 24
$1.4B
$1.3B
Net Profit
EW
EW
RKT
RKT
Q1 26
$380.7M
Q4 25
$91.2M
$68.0M
Q3 25
$291.1M
$-123.9M
Q2 25
$333.2M
$-1.8M
Q1 25
$358.0M
$-10.4M
Q4 24
$385.6M
$33.9M
Q3 24
$3.1B
$-22.0M
Q2 24
$366.3M
$1.3M
Gross Margin
EW
EW
RKT
RKT
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
Q2 25
77.5%
Q1 25
78.7%
Q4 24
78.9%
58.9%
Q3 24
80.6%
-8.4%
Q2 24
79.9%
47.4%
Operating Margin
EW
EW
RKT
RKT
Q1 26
1.8%
Q4 25
9.6%
6.3%
Q3 25
19.8%
-11.5%
Q2 25
26.8%
1.8%
Q1 25
27.9%
-21.5%
Q4 24
22.6%
38.1%
Q3 24
25.9%
-76.9%
Q2 24
26.8%
14.8%
Net Margin
EW
EW
RKT
RKT
Q1 26
23.1%
Q4 25
5.8%
2.5%
Q3 25
18.7%
-7.7%
Q2 25
21.7%
-0.1%
Q1 25
25.3%
-1.0%
Q4 24
27.8%
1.9%
Q3 24
226.7%
-3.4%
Q2 24
26.7%
0.1%
EPS (diluted)
EW
EW
RKT
RKT
Q1 26
$0.66
Q4 25
$0.16
$0.10
Q3 25
$0.50
$-0.06
Q2 25
$0.56
$-0.01
Q1 25
$0.61
$-0.08
Q4 24
$0.65
$0.28
Q3 24
$5.13
$-0.19
Q2 24
$0.61
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
RKT
RKT
Cash + ST InvestmentsLiquidity on hand
$2.7B
Total DebtLower is stronger
Stockholders' EquityBook value
$22.9B
Total Assets
$60.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
RKT
RKT
Q1 26
Q4 25
$4.2B
$2.7B
Q3 25
$3.8B
$5.8B
Q2 25
$4.1B
$5.1B
Q1 25
$3.9B
$1.4B
Q4 24
$4.0B
$1.3B
Q3 24
$4.4B
$1.2B
Q2 24
$2.0B
$1.3B
Stockholders' Equity
EW
EW
RKT
RKT
Q1 26
Q4 25
$10.3B
$22.9B
Q3 25
$10.2B
$8.9B
Q2 25
$10.5B
$7.4B
Q1 25
$10.1B
$8.6B
Q4 24
$10.0B
$9.0B
Q3 24
$9.5B
$8.4B
Q2 24
$7.4B
$8.8B
Total Assets
EW
EW
RKT
RKT
Q1 26
Q4 25
$13.7B
$60.7B
Q3 25
$13.3B
$33.6B
Q2 25
$13.5B
$30.4B
Q1 25
$13.0B
$25.3B
Q4 24
$13.1B
$24.5B
Q3 24
$13.0B
$25.1B
Q2 24
$10.1B
$23.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
RKT
RKT
Operating Cash FlowLast quarter
$-1.2B
Free Cash FlowOCF − Capex
$-1.3B
FCF MarginFCF / Revenue
-47.2%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
-18.08×
TTM Free Cash FlowTrailing 4 quarters
$-4.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
RKT
RKT
Q1 26
Q4 25
$450.9M
$-1.2B
Q3 25
$573.7M
$-50.3M
Q2 25
$290.2M
$-1.9B
Q1 25
$280.4M
$-797.0M
Q4 24
$-127.5M
$1.8B
Q3 24
$351.8M
$-1.3B
Q2 24
$371.5M
$-122.3M
Free Cash Flow
EW
EW
RKT
RKT
Q1 26
Q4 25
$353.5M
$-1.3B
Q3 25
$516.2M
$-71.8M
Q2 25
$240.9M
$-1.9B
Q1 25
$224.4M
$-811.0M
Q4 24
$-177.3M
$1.8B
Q3 24
$299.9M
$-1.4B
Q2 24
$286.1M
$-138.3M
FCF Margin
EW
EW
RKT
RKT
Q1 26
Q4 25
22.5%
-47.2%
Q3 25
33.2%
-4.5%
Q2 25
15.7%
-137.2%
Q1 25
15.9%
-78.2%
Q4 24
-12.8%
103.1%
Q3 24
22.1%
-209.6%
Q2 24
20.9%
-10.6%
Capex Intensity
EW
EW
RKT
RKT
Q1 26
Q4 25
6.2%
1.5%
Q3 25
3.7%
1.3%
Q2 25
3.2%
1.1%
Q1 25
4.0%
1.4%
Q4 24
3.6%
1.1%
Q3 24
3.8%
2.9%
Q2 24
6.2%
1.2%
Cash Conversion
EW
EW
RKT
RKT
Q1 26
Q4 25
4.94×
-18.08×
Q3 25
1.97×
Q2 25
0.87×
Q1 25
0.78×
Q4 24
-0.33×
54.42×
Q3 24
0.11×
Q2 24
1.01×
-94.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

RKT
RKT

Other$1.4B51%
Direct To Customer Segment$945.8M35%
Partner Network Segment$216.7M8%
Subscription Revenue$91.3M3%
Closing Fees$47.1M2%
Appraisal Revenue$10.7M0%

Related Comparisons